[{"id":"3fbec8f0-562c-408b-bedc-57e462d5b5fd","acronym":"","url":"https://clinicaltrials.gov/study/NCT03531632","created_at":"2021-01-18T17:23:48.934Z","updated_at":"2024-07-02T16:36:17.424Z","phase":"Phase 1b/2","brief_title":"MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer","source_id_and_acronym":"NCT03531632","lead_sponsor":"MacroGenics","biomarkers":" PD-L1 • PD-1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1 • PD-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Zynyz (retifanlimab-dlwr) • MGD007"],"overall_status":"Completed","enrollment":" Enrollment 38","initiation":"Initiation: 06/04/2018","start_date":" 06/04/2018","primary_txt":" Primary completion: 02/08/2020","primary_completion_date":" 02/08/2020","study_txt":" Completion: 02/08/2020","study_completion_date":" 02/08/2020","last_update_posted":"2022-02-08"}]